Literature DB >> 11842279

R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis.

G Tautermann1, H Ruebsamen, M Beck, S Dertinger, H Drexel, P Lohse.   

Abstract

Hereditary pancreatitis is due to heterozygosity for gain-of-function mutations in the cationic trypsinogen gene which result in increased levels of active trypsin within pancreatic acinar cells and autodigestion of the pancreas. The number of disease-causing defects is generally considered to be low. To gain further insight into the molecular basis of this disorder, DNA sequence analysis of all five exons was performed in 109 unrelated patients with idiopathic chronic pancreatitis in order to determine the variability of the underlying mutations. Two German females and one German male were carriers of the most common N29I and R122H mutations (trypsinogen numbering system). In a Turkish proband, an arginine (CGT) to cysteine (TGT) substitution at amino acid position 116 was identified. Family screening demonstrated that the patient had inherited the mutation from his asymptomatic father and that he had transmitted it to both of his children, his daughter being symptomatic since the age of 3 years. In addition, a German male was found to be a heterozygote for a D100H (GAC-->CAC) amino acid replacement. Our data provide evidence for genetic heterogeneity of hereditary pancreatitis. The growing number of cationic trypsinogen mutations is expected to change current mutation screening practices for this disease. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11842279     DOI: 10.1159/000048866

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

Review 1.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 2.  Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Authors:  Balázs Csaba Németh; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

3.  A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene.

Authors:  Theeraphong Pho-Iam; Wanna Thongnoppakhun; Pa-Thai Yenchitsomanus; Chanin Limwongse
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Evaluation of the cationic trypsinogen gene for potential mutations in miniature schnauzers with pancreatitis.

Authors:  Micah A Bishop; Jörg M Steiner; Lisa E Moore; David A Williams
Journal:  Can J Vet Res       Date:  2004-10       Impact factor: 1.310

5.  Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.

Authors:  Andrea Schnúr; Sebastian Beer; Heiko Witt; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Gut       Date:  2013-03-01       Impact factor: 23.059

Review 6.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.

Authors:  Eva Kereszturi; Richárd Szmola; Zoltán Kukor; Peter Simon; Frank Ulrich Weiss; Markus M Lerch; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

Review 8.  Genetic risk in chronic pancreatitis: the misfolding-dependent pathway.

Authors:  Miklós Sahin-Tóth
Journal:  Curr Opin Gastroenterol       Date:  2017-09       Impact factor: 3.287

Review 9.  Targeting Endoplasmic Reticulum Stress as an Effective Treatment for Alcoholic Pancreatitis.

Authors:  Hui Li; Wen Wen; Jia Luo
Journal:  Biomedicines       Date:  2022-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.